InvestorsHub Logo

Cubflyer1946

09/09/21 9:39 AM

#339784 RE: Protector #339780

It is not the product already delivered to HGEN, it is the expectation that CDMO would be manufacturing Lenzilumab for commercial distribution going forward. That is not going to happen in the foreseeable future, hence the drop in CDMO! POS!

peregr

09/09/21 9:45 AM

#339790 RE: Protector #339780

I would hope the analysts notes that come out today can confirm no change in guidance due to HGEN.